Inovio talks monoclonal antibodies, DNA plasmid technology, shares rise

Inovio Pharmaceuticals announces the publication of a peer-reviewed paper which outlines a study wherein the delivery of a DNA-based monoclonal antibody triggered the generation of antibody molecules "possessing desirable functional activity including high antigen-binding and HIV-neutralization capabilities against diverse strains of HIV viruses ... (more)

http://seekingalpha.com/currents/post/1295832?source=feed